These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Extracellular vesicle-mediated delivery of CRISPR/Cas9 ribonucleoprotein complex targeting proprotein convertase subtilisin-kexin type 9 (Pcsk9) in primary mouse hepatocytes. Ilahibaks NF; Kluiver TA; de Jong OG; de Jager SCA; Schiffelers RM; Vader P; Peng WC; Lei Z; Sluijter JPG J Extracell Vesicles; 2024 Jan; 13(1):e12389. PubMed ID: 38191764 [TBL] [Abstract][Full Text] [Related]
4. Engineering extracellular vesicles to deliver CRISPR ribonucleoprotein for gene editing. Whitley JA; Cai H J Extracell Vesicles; 2023 Sep; 12(9):e12343. PubMed ID: 37723839 [TBL] [Abstract][Full Text] [Related]
5. Small extracellular vesicle-mediated CRISPR-Cas9 RNP delivery for cardiac-specific genome editing. Mun D; Kang JY; Kim H; Yun N; Joung B J Control Release; 2024 Jun; 370():798-810. PubMed ID: 38754633 [TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of lipid Nanoparticle-Mediated delivery of CRISPR-Cas9 RNP versus mRNA/sgRNA for gene editing in vitro and in vivo. Walther J; Porenta D; Wilbie D; Seinen C; Benne N; Yang Q; de Jong OG; Lei Z; Mastrobattista E Eur J Pharm Biopharm; 2024 Mar; 196():114207. PubMed ID: 38325664 [TBL] [Abstract][Full Text] [Related]
10. Engineered extracellular vesicles as versatile ribonucleoprotein delivery vehicles for efficient and safe CRISPR genome editing. Yao X; Lyu P; Yoo K; Yadav MK; Singh R; Atala A; Lu B J Extracell Vesicles; 2021 Mar; 10(5):e12076. PubMed ID: 33747370 [TBL] [Abstract][Full Text] [Related]
11. The CRISPR/Cas9 System Delivered by Extracellular Vesicles. Zhu X; Gao M; Yang Y; Li W; Bao J; Li Y Pharmaceutics; 2023 Mar; 15(3):. PubMed ID: 36986843 [TBL] [Abstract][Full Text] [Related]
12. Preparation of NanoMEDIC Extracellular Vesicles to Deliver CRISPR-Cas9 Ribonucleoproteins for Genomic Exon Skipping. Watanabe K; Gee P; Hotta A Methods Mol Biol; 2023; 2587():427-453. PubMed ID: 36401042 [TBL] [Abstract][Full Text] [Related]
13. Encapsulating Cas9 into extracellular vesicles by protein myristoylation. Whitley JA; Kim S; Lou L; Ye C; Alsaidan OA; Sulejmani E; Cai J; Desrochers EG; Beharry Z; Rickman CB; Klingeborn M; Liu Y; Xie ZR; Cai H J Extracell Vesicles; 2022 Apr; 11(4):e12196. PubMed ID: 35384352 [TBL] [Abstract][Full Text] [Related]
14. Tropism-facilitated delivery of CRISPR/Cas9 system with chimeric antigen receptor-extracellular vesicles against B-cell malignancies. Xu Q; Zhang Z; Zhao L; Qin Y; Cai H; Geng Z; Zhu X; Zhang W; Zhang Y; Tan J; Wang J; Zhou J J Control Release; 2020 Oct; 326():455-467. PubMed ID: 32711027 [TBL] [Abstract][Full Text] [Related]
15. High content analysis platform for optimization of lipid mediated CRISPR-Cas9 delivery strategies in human cells. Steyer B; Carlson-Stevermer J; Angenent-Mari N; Khalil A; Harkness T; Saha K Acta Biomater; 2016 Apr; 34():143-158. PubMed ID: 26747759 [TBL] [Abstract][Full Text] [Related]
16. Engineered extracellular vesicles for delivering functional Cas9/gRNA to eliminate hepatitis B virus cccDNA and integration. Zeng W; Zheng L; Li Y; Yang J; Mao T; Zhang J; Liu Y; Ning J; Zhang T; Huang H; Chen X; Lu F Emerg Microbes Infect; 2024 Dec; 13(1):2284286. PubMed ID: 37982370 [TBL] [Abstract][Full Text] [Related]
17. Biomaterial-assisted targeted and controlled delivery of CRISPR/Cas9 for precise gene editing. Iqbal Z; Rehman K; Xia J; Shabbir M; Zaman M; Liang Y; Duan L Biomater Sci; 2023 May; 11(11):3762-3783. PubMed ID: 37102700 [TBL] [Abstract][Full Text] [Related]
18. New Therapeutics for Extracellular Vesicles: Delivering CRISPR for Cancer Treatment. Yan B; Liang Y Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555398 [TBL] [Abstract][Full Text] [Related]